Johannes Fredebohm

748 total citations
23 papers, 581 citations indexed

About

Johannes Fredebohm is a scholar working on Cancer Research, Molecular Biology and Oncology. According to data from OpenAlex, Johannes Fredebohm has authored 23 papers receiving a total of 581 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Cancer Research, 11 papers in Molecular Biology and 9 papers in Oncology. Recurrent topics in Johannes Fredebohm's work include Cancer Genomics and Diagnostics (15 papers), Pancreatic and Hepatic Oncology Research (5 papers) and Head and Neck Cancer Studies (4 papers). Johannes Fredebohm is often cited by papers focused on Cancer Genomics and Diagnostics (15 papers), Pancreatic and Hepatic Oncology Research (5 papers) and Head and Neck Cancer Studies (4 papers). Johannes Fredebohm collaborates with scholars based in Germany, United States and Spain. Johannes Fredebohm's co-authors include Jörg D. Hoheisel, Frank Holtrup, Michael Boettcher, Frank Diehl, Jonas Michel Wolf, Karin Müller‐Decker, Christa Flechtenmacher, Dyah Laksmi Dewi, Warren P. Tate and Jennifer L. Murphy and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

In The Last Decade

Johannes Fredebohm

21 papers receiving 574 citations

Peers

Johannes Fredebohm
Patrick Dospoy United States
Jianguo Lai China
Dianke Chen China
Shi-Xun Lu China
Daniel R. Zweitzig United States
Alice Lallo United Kingdom
Mingxin Wen China
Maria Cardenas United States
Sven‐Thorsten Liffers Germany
Huili Chu China
Patrick Dospoy United States
Johannes Fredebohm
Citations per year, relative to Johannes Fredebohm Johannes Fredebohm (= 1×) peers Patrick Dospoy

Countries citing papers authored by Johannes Fredebohm

Since Specialization
Citations

This map shows the geographic impact of Johannes Fredebohm's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Johannes Fredebohm with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Johannes Fredebohm more than expected).

Fields of papers citing papers by Johannes Fredebohm

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Johannes Fredebohm. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Johannes Fredebohm. The network helps show where Johannes Fredebohm may publish in the future.

Co-authorship network of co-authors of Johannes Fredebohm

This figure shows the co-authorship network connecting the top 25 collaborators of Johannes Fredebohm. A scholar is included among the top collaborators of Johannes Fredebohm based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Johannes Fredebohm. Johannes Fredebohm is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Murray, David H., A. Keyser, Oliver Schauer, et al.. (2024). Abstract A019: Analytical and clinical validation of HPV-SEQ, an NGS-based liquid biopsy platform for detection and quantification of human papilloma virus circulating tumor DNA. Clinical Cancer Research. 30(21_Supplement). A019–A019. 2 indexed citations
2.
Economopoulou, Panagiota, Aris Spathis, Ioannis Kotsantis, et al.. (2023). Next-generation sequencing (NGS) profiling of matched tumor and circulating tumor DNA (ctDNA) in head and neck squamous cell carcinoma (HNSCC). Oral Oncology. 139. 106358–106358. 11 indexed citations
3.
Kobilay, Makbule, Dirk Skowasch, Abel J. Bronkhorst, et al.. (2023). Pre-Analytical Evaluation of Streck Cell-Free DNA Blood Collection Tubes for Liquid Profiling in Oncology. Diagnostics. 13(7). 1288–1288. 26 indexed citations
4.
Zamora, Esther, Santiago Escrivá-de-Romaní, José Jiménez, et al.. (2022). Clearance of ctDNA in triple-negative and HER2-positive breast cancer patients during neoadjuvant treatment is correlated with pathologic complete response. Therapeutic Advances in Medical Oncology. 14. 4287551633–4287551633. 7 indexed citations
5.
Rosenberg, Ari J., Evgeny Izumchenko, Alexander T. Pearson, et al.. (2022). Prospective study evaluating dynamic changes of cell-free HPV DNA in locoregional viral-associated oropharyngeal cancer treated with induction chemotherapy and response-adaptive treatment. BMC Cancer. 22(1). 17–17. 9 indexed citations
6.
Jeffers, Michael, Christian Kappeler, Iris Kuss, et al.. (2022). Broad spectrum of regorafenib activity on mutant KIT and absence of clonal selection in gastrointestinal stromal tumor (GIST): correlative analysis from the GRID trial. Gastric Cancer. 25(3). 598–608. 5 indexed citations
7.
Rosenberg, Ari J., et al.. (2022). Evaluation of Cell-Free HPV DNA in Patients With HPV-Associated Oropharyngeal Cancer Treated With Induction Chemotherapy and Response-Adaptive Therapy. International Journal of Radiation Oncology*Biology*Physics. 112(5). e19–e19.
8.
Sloane, Hillary S., Evgeny Izumchenko, Austin K. Mattox, et al.. (2021). Ultra-sensitive detection and quantification of HPV DNA in the plasma of patients with oropharyngeal squamous cell carcinoma (OPSCC) enrolled in the OPTIMA 2 treatment de-escalation trial.. Journal of Clinical Oncology. 39(15_suppl). 6048–6048. 6 indexed citations
9.
10.
Álvarez, Martina, Luís Vicioso, Cristina Hernándo, et al.. (2019). Detection of TP53 and PIK3CA Mutations in Circulating Tumor DNA Using Next-Generation Sequencing in the Screening Process for Early Breast Cancer Diagnosis. Journal of Clinical Medicine. 8(8). 1183–1183. 44 indexed citations
11.
Vicioso, Luís, Vanessa de Luque, Cristina Hernándo, et al.. (2018). Plasma sequencing of ctDNA in early stage breast cancer as part of the screening process.. Journal of Clinical Oncology. 36(15_suppl). 12073–12073. 2 indexed citations
12.
Fredebohm, Johannes, et al.. (2016). Detection and Quantification of KIT Mutations in ctDNA by Plasma Safe-SeqS. Advances in experimental medicine and biology. 924. 187–189. 18 indexed citations
13.
Fredebohm, Johannes, et al.. (2016). Performance of Streck cfDNA Blood Collection Tubes for Liquid Biopsy Testing. PLoS ONE. 11(11). e0166354–e0166354. 147 indexed citations
14.
Cheng, Xinlai, Jee Young Kim, Shahrouz Ghafoory, et al.. (2016). Methylisoindigo preferentially kills cancer stem cells by interfering cell metabolism via inhibition of LKB1 and activation of AMPK in PDACs. Molecular Oncology. 10(6). 806–824. 40 indexed citations
15.
Boettcher, Michael, Andrew Lawson, Johannes Fredebohm, et al.. (2014). High throughput synthetic lethality screen reveals a tumorigenic role of adenylate cyclase in fumarate hydratase-deficient cancer cells. BMC Genomics. 15(1). 158–158. 17 indexed citations
16.
Wolf, Jonas Michel, Dyah Laksmi Dewi, Johannes Fredebohm, et al.. (2013). A mammosphere formation RNAi screen reveals that ATG4A promotes a breast cancer stem-like phenotype. Breast Cancer Research. 15(6). R109–R109. 112 indexed citations
17.
Fredebohm, Johannes, Jonas Michel Wolf, Jörg D. Hoheisel, & Michael Boettcher. (2013). Depletion of RAD17 sensitizes pancreatic cancer cells to gemcitabine. Journal of Cell Science. 126(Pt 15). 3380–9. 25 indexed citations
18.
Fredebohm, Johannes, Michael Boettcher, Christian Eisen, et al.. (2012). Establishment and Characterization of a Highly Tumourigenic and Cancer Stem Cell Enriched Pancreatic Cancer Cell Line as a Well Defined Model System. PLoS ONE. 7(11). e48503–e48503. 37 indexed citations
19.
20.
Boettcher, Michael, Johannes Fredebohm, Amin Moghaddas Gholami, et al.. (2010). Decoding pooled RNAi screens by means of barcode tiling arrays. BMC Genomics. 11(1). 7–7. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Patrick Dospoy Breakdown of academic impact, for papers by Jianguo Lai Breakdown of academic impact, for papers by Dianke Chen Breakdown of academic impact, for papers by Shi-Xun Lu Breakdown of academic impact, for papers by Daniel R. Zweitzig Breakdown of academic impact, for papers by Alice Lallo Breakdown of academic impact, for papers by Mingxin Wen Breakdown of academic impact, for papers by Maria Cardenas Breakdown of academic impact, for papers by Sven‐Thorsten Liffers Breakdown of academic impact, for papers by Huili Chu
Rankless by CCL
2026